Device type · LPA
System, Esophageal Pacing
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
LPA
Cardiovascular
Device class
Class III
FDA decisions since 2015
0
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- System, Esophageal Pacing
- Product code
- LPA
- Device class
- Class III
- Review panel
- Cardiovascular
- Specialty
- Cardiology, Electrophysiology
- FDA record
- Classification database entry for LPA
Latest FDA decisions
No 510(k), De Novo or PMA decisions for this product code since 2015.
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- TAPSYSTEM Model 2A, REF 8002ATerminated
Z-1976-2019 · Started Jun 24, 2019
Reason given: There is a potential for an assembly error resulting in the battery wire being connected to the ON/OFF power switch incorrectly.
Cause as FDA categorized it: Process control
Z-1773-2019 · Started May 10, 2019
Reason given: Possible corrosion of the battery contact(s).
Cause as FDA categorized it: Process control
Z-0071-2012 · Started Oct 25, 2010 · Posted by FDA Oct 19, 2011
Reason given: CardioCommand, Inc. is recalling their TAPSCOPE 550 esophageal pacing/recording catheters because there maybe electrical discontinuity, which can result in the inability to reliably pace and/or record ECG.
Cause as FDA categorized it: Nonconforming Material/Component
Z-0072-2012 · Started Oct 25, 2010 · Posted by FDA Oct 19, 2011
Reason given: CardioCommand, Inc. is recalling their TAPSCOPE 550 esophageal pacing/recording catheters because there maybe electrical discontinuity, which can result in the inability to reliably pace and/or record ECG.
Cause as FDA categorized it: Nonconforming Material/Component
Z-0568-04 · Started Oct 27, 2003 · Posted by FDA Jul 20, 2004
Reason given: The device may exhibit spurious heart rate increase during esophageal atrial pacing during simultaneous adjacent use of electrosurgical coagulation devices.
Cause as FDA categorized it: Other
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.